How do you manage reputation during a pharmaceutical product recall?

A pharmaceutical product recall is a high-stakes information event where misinformation can directly affect patient safety, so the reputation work runs tightly alongside regulatory and medical communication. The priority is factual, regulatory-aware customer-facing content that gives patients and providers a clear account of the recall, the affected products, and what to do, coordinated with the FDA notification process. The reputational risk is amplification of inaccuracy: recalls generate fear-driven coverage and social chatter, and AI engines synthesize it into confident answers that may overstate scope or risk. We monitor those answers across the engines with AIQ specifically to catch and correct misinformation about the recall’s extent and meaning. The durable work follows the acute phase: authoritative content on the remediation taken and the safety controls now in place, so the public record reflects a company that managed a recall responsibly rather than one defined by the event. In pharma, getting the facts right outranks getting them out fast.